Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare (NASDAQ: ADUS) remains on the hunt.
The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. Addus has been among the few publicly traded companies that have remained active acquirers, and more deals are likely on the way during the fourth quarter and into 2024. Going forward, Addus plans to continue its long-standing acquisition strategy — designed to co-locate all three of its service lines in certain markets, Hospice News reports. Read more.
